Vitamina C

Sodium Ascorbate

Method of action: Antioxidant, Metabolic, Nutritive Agent, Regulating Redox Processes, Replenishing Vitamin C Deficiency, Vitamins

Treatment option: Beriberi, Anemia, Pregnancy, Addison Disease, Milk Ejection, Radiation Sickness, Nephropathy, Scurvy

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitamina C

What is Vitamina C? (Sodium Ascorbate)

Property	Description
Active ingredient	Ascorbic acid (as Sodium Ascorbate)
Form	Solution, Tablet, Capsule, Powder
Pharmacological class	Vitamin; Antiscorbutic agent
Common use	Prevention and treatment of deficiency
Origin	Synthetic (Pharmaceutical Grade)

Identity and Pharmacological Classification

Vitamina C, chemically known as Ascorbic acid or L-ascorbic acid, is a required essential nutrient and is categorized as a water-soluble vitamin. As a medical preparation, it is classified within the pharmacological class of vitamins and nutritional supplements, recognized specifically as an antiscorbutic agent. This designation confirms its fundamental role in addressing vitamin deficiency.

Because the human body cannot produce its own supply of Ascorbic acid, it must be acquired externally, classifying it as an exogenous substance. Pharmaceutical products, typically of synthetic, high-purity grade, are used to reliably manage confirmed deficiency states. The pharmaceutical status of the substance is supported by extensive pharmacological studies detailing its essential biochemical functions.

Composition and Available Forms

The primary active compound is the Ascorbate moiety, frequently delivered as Sodium Ascorbate, which is the non-acidic salt of ascorbic acid. This mineral ascorbate is favored in many clinical settings because it is more chemically stable and offers greater tolerability than free Ascorbic acid. This formulation distinction is key for patient comfort, particularly in high-dose scenarios where it is clinically recognized for efficient absorption.

Vitamina C is supplied in various dosage form(s), including oral forms like tablet and capsule, and in injectable solution form for Parenteral administration. This variety ensures the medicine can be delivered effectively, whether for routine supplementation or severe deficiency.

General Purpose: Addressing Essential Nutrient Deficiency

The overarching purpose of Vitamina C medication is to correct or prevent hypovitaminosis C, the clinical state resulting from a confirmed deficiency, and related conditions like scurvy. By supplying this crucial substance, the treatment supports the body's ability to maintain essential physiological functions, including serving as an indispensable cofactor for collagen synthesis and acting as a broad-spectrum antioxidant.

Regulatory References

Ascorbic acid on WHO Model List of Essential Medicines

What side effects are possible with Vitamina C?

Possible Side Effects and Safety Information

Vitamina C (Ascorbic Acid) is generally well-tolerated at typical supplemental doses. Adverse reactions primarily affect the gastrointestinal system and are often associated with high-dose use.

Adverse Reaction Categories

System-Organ Class	Potential Adverse Reactions (Common/Less Common)
Gastrointestinal	Nausea, vomiting, diarrhea, stomach cramps/upset.
Nervous System	Headache, dizziness (particularly with rapid intravenous administration).
Local Reactions	Pain and swelling at the injection or infusion site.
Urinary System	Increased urination.

Serious and Clinically Significant Safety Concerns

The most serious documented safety concerns are dose-related and population-specific, typically occurring with high-dose intravenous or prolonged use:

Oxalate Nephropathy and Nephrolithiasis (Kidney Stones): High doses of Ascorbic Acid can significantly increase urinary oxalate and uric acid levels, raising the risk of oxalate crystal deposition in the renal tubules, which may lead to kidney stone formation or acute renal injury, especially in individuals with pre-existing renal impairment or a history of kidney stones.
Hemolysis in G6PD Deficiency: Patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are at risk of severe hemolysis (destruction of red blood cells) when administered high doses of Ascorbic Acid. G6PD deficiency is considered a contraindication for high-dose intravenous use.

Safety Considerations and Restrictions

Population Risk: Caution is required in patients with renal disease, a history of nephrolithiasis, and G6PD deficiency. Use in these groups should be closely monitored.
Dose/Exposure: The risks of oxalate-related renal injury are explicitly linked to high-dose or prolonged administration.
Laboratory Interference: Ascorbic Acid may interfere with certain laboratory tests that rely on oxidation-reduction reactions, including blood and urine glucose monitoring systems, potentially yielding inaccurate results.

Overdose and Emergency Response

The official regulatory documents state that overdosage of Vitamina C (Ascorbic Acid) is defined by a range of documented clinical manifestations and specific severe outcomes. Common signs associated with high-dose or excessive intake are primarily gastrointestinal disturbances, including diarrhea, nausea, vomiting, and stomach cramps. Other documented presentations include headache, skin flushing, and a diuretic effect observed at daily doses above 600 mg.

The most critical regulatory concern involves potentially life-threatening outcomes, particularly within at-risk populations. Massive overdosage can lead to renal failure and the formation of renal oxalate calculi, potentially progressing to acute or chronic oxalate nephropathy. Furthermore, individuals with a deficiency of Glucose-6-phosphate dehydrogenase (G6PD) are at an explicit risk of severe haemolytic anaemia and acidosis.

Urgent medical attention is required immediately upon the suspicion of these severe manifestations, such as signs of renal impairment or haemolysis. The official management procedures are strictly symptomatic and supportive, and may involve gastric lavage if the ingestion was recent. There is no specific antidote documented in regulatory prescribing information. Monitoring of renal function and blood counts is mandated for certain at-risk patients.

Therapeutic Uses of Vitamina C

What Vitamin C Treats: Main Uses and Benefits

Vitamin C is commonly used to support various processes in the body, and is relevant when supportive symptom management is appropriate.

Supporting Symptom Management and Functional Stability

Vitamin C is often applied across domains where additional symptomatic support is needed, and is relevant in contexts marked by increased discomfort or tension or when symptoms that interfere with daily functioning are present. It is commonly used to help manage symptoms associated with conditions that involve episodic or fluctuating manifestations, acute episodes, and those marked by increased discomfort or tension. The nutrient is relevant when supportive symptom management is appropriate. It generally provides support that helps ease the overall symptom burden and assists with maintaining functional stability when symptoms create noticeable interference with daily comfort. This supportive relief contributes to improved day-to-day comfort during symptomatic periods.

“May assist with maintaining functional stability.”

Quick Fact: Supports management of Noticeable Physiological Strain

Eligibility and Restrictions for Use

Official Population Eligibility for Vitamina C

The eligibility for pharmaceutical Vitamina C (Ascorbic acid/Sodium Ascorbate) is strictly defined by government regulatory documents, outlining populations that are approved, restricted, or absolutely prohibited from use.

Populations for Whom Use is Contraindicated

Use of the medicine is contraindicated (absolutely prohibited) for patients with a known hypersensitivity to the active substance or excipients. Contraindication also applies to patients with pre-existing hyperoxaluria (excessive oxalate in the urine), due to the risk of stone formation.

Age-Group and Condition-Specific Restrictions

The medicine is officially approved for adults and pediatric patients age 5 months and older for deficiency treatment. However, use requires caution and is restricted in several populations:

Renal Impairment: Patients with renal disease or a history of kidney stones are at increased risk of oxalate nephropathy (oxalate precipitation) and may be restricted to low daily intakes.
Metabolic Disorders: Individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency are restricted to a dose that does not exceed the Recommended Dietary Allowance (RDA) to mitigate the risk of severe hemolysis.
Physiological States: Pregnant and lactating women must also not exceed the U.S. RDA or Adequate Intake level.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information documents specific interaction patterns for Ascorbic acid (Vitamina C) based on its chemical properties and effects on other medications. These interactions are classified primarily as pharmacokinetic interference and specific pharmacodynamic risks.

Documented Interaction Patterns

Classification	Interacting Substance/Class	Official Regulatory Statement
Contraindicated/Avoidance Required	Deferoxamine	Strict avoidance or timing separation is required in patients with pre-existing cardiac failure due to the risk of cardiac dysfunction.
Pharmacokinetic Interference	Basic Drugs (e.g., Amphetamine)	Ascorbic acid may cause urine acidification, resulting in increased renal clearance and a consequent decrease in the plasma concentration of basic medicines.
Exposure Modification	Oral Contraceptives	May increase serum levels of estrogens in oral contraceptives, potentially due to decreased hormone metabolism.
Pharmacodynamic Effect	Oral Anticoagulants (e.g., Warfarin)	High doses may result in a reduction of the anticoagulant effect, requiring cautious co-administration and monitoring.
Food/Supplement Interaction	Nonheme Iron Supplements	Enhances the absorption of nonheme iron from both food and supplements.

Restrictions and Timing Rules

Co-administration with Deferoxamine requires mandatory timing separation; if Vitamin C is administered, it must be delayed for one month after the start of Deferoxamine treatment. The severity of the interaction with Deferoxamine is heightened in patient populations with iron overload or cardiac compromise, where co-use is strictly avoided.

Mechanism of Action

How Vitamina C Works — Mechanism of Action

Vitamina C, or Ascorbate, functions primarily as an essential reducing agent by donating electrons to various enzymes, most notably the hydroxylase family. This electron donation maintains the ferrous state ( Fe^2+) of the enzyme cofactor, which is required for the hydroxylation of proline and lysine residues. This specific biochemical step is fundamental for collagen's triple-helix structure within connective tissues.

Furthermore, Ascorbate acts as a water-soluble antioxidant by directly neutralizing Reactive Oxygen Species (ROS), such as free radicals, which protects critical cellular components from oxidative damage. As a cofactor, it is also required for the synthesis of the neurotransmitter norepinephrine and carnitine (essential for fatty acid transport). Finally, it enhances the intestinal absorption of dietary iron by reducing ferric iron ( Fe^3+) to the more available ferrous form ( Fe^2+).

Dosage and Administration Information

Instruction Map: How to use Vitamina C — Administration Guidelines

The usage of pharmaceutical Vitamina C (Ascorbic Acid) is governed by specific instructions that define the route, preparation, and duration of the treatment.

Category	Instruction Entity
Route of administration	Intravenous (IV) Infusion is the route for acute deficiency; Oral (PO) forms (tablets, capsules, liquid) are used for general correction.
Dosing schedule (Adults and ge 11 years)	IV Dose: 200 mg once daily. Oral Dose: Typically 100 mg to 250 mg daily for scurvy treatment.
Timing in relation to meals	Oral forms may be taken with or without food.
Preparation requirements	The high-concentration IV solution must be diluted prior to administration to achieve a final concentration between 1 mg/mL and 25 mg/mL in an isotonic vehicle.
Age-group administration rules	Pediatric IV Doses (1 to < 11 years) are 100 mg once daily; infants (5 months to < 12 months) require 50 mg once daily.
Special procedural conditions	Administration must be a slow intravenous infusion, not a direct, undiluted injection. The oral extended-release forms should not be crushed.

Instruction Classifications (High-Level)

Category	Classification Entity
Administration method type	Oral and Parenteral (Intravenous, Intramuscular, Subcutaneous).
Frequency pattern	Once daily (qDay) is the required pattern for the intravenous route and common for oral use.
Use-context constraints	The intravenous route is indicated for short-term use, with a maximum recommended duration of seven days.

Resulting Procedural Structure

Standard step sequence:

Prepare IV Solution: Dilute the injectable concentrate to the required isotonic concentration, typically within a pharmacy admixture program.
Administer Daily Dose: Administer the prescribed once-daily dose via slow intravenous infusion, or orally with or without food.
Monitor Duration: Limit the intravenous treatment course to a maximum of one week; oral treatment may continue for a minimum of two weeks.

Connection to the overall use protocol: Established protocols define a structured approach to administration by prescribing distinct routes, specific dose ranges, and mandatory preparation steps based on the form chosen. This framework standardizes the drug's application by linking high-level frequency patterns (once daily) to defined maximum durations, ensuring consistent procedural compliance.

Recent Clinical Evidence

Research evidence / Overview of studies for Vitamina C

Evidence for Use in Confirmed Deficiency and Scurvy

Research has studied for many years how studies have investigated severe deficiency and the related condition of scurvy. The body of evidence includes historical depletion-repletion studies and modern case reports that research describes in contemporary patient settings. These studies have monitored outcomes related to systemic or functional imbalance, such as the reversal of classic clinical signs and the restoration of Ascorbic acid biomarker levels in the blood of individuals with confirmed deficiency. Findings describe patterns observed in the studies where providing Ascorbic acid was observed in patients to correlate with observed shifts in these essential physiological measures.

Evidence for Supportive Management in Sub-Optimal Status

Research explored the potential role of Ascorbic acid in observational settings evaluating daily-life functioning and in controlled clinical trials focused on individuals with sub-optimal vitamin C status. These studies have examined outcomes related to outcomes monitoring physiological strain or stress. Data show patterns related to an association between low or sub-optimal Ascorbic acid levels and certain markers of health status. However, findings were mixed regarding changes in complex functional outcomes when compared across diverse trial settings. This is because evidence quality varies across studies, and results often reflect observations rather than direct cause-and-effect conclusions.

Long-Term Research and Follow-up Durations

The duration of patient monitoring in studies researching Vitamina C varies based on the type of evidence. For the core studies related to severe deficiency reversal, researchers have typically monitored patients over intermediate-term durations to track the evolution toward sustained clinical and functional stability. For other supportive studies, the follow-up durations were limited, often focusing on short-term symptom changes. Therefore, there is limited information for long-term outcomes regarding the durability of effects or the patterns related to maintenance supplementation outside of preventing a relapse into deficiency.

Evidence in Specific Groups of People

Research examined Ascorbic acid status and supplementation in various specific populations. Studies have observed in populations such as older adults, hospitalized adult patients with chronic illness, and individuals with certain underlying health conditions marked by functional limitations that can affect absorption or metabolism. These groups are included in studies due to chronic conditions or restricted diets. Results apply only to the populations studied, and findings often reflect the high prevalence of sub-optimal vitamin C status in these vulnerable settings.

What is Still Uncertain About Vitamina C Research

The overall research landscape for Vitamina C highlights what is known — and what is still uncertain. For its primary role in deficiency, while foundational evidence is consistent, comparative evidence is lacking from large, modern randomized trials. In other areas of supportive use, evidence quality varies across studies due to heterogeneity in the patient groups and the way outcomes were measured. Overall, the long-term effects are not fully established for all populations, and research is ongoing to provide further insight into observed patterns.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Vitamina C (FAQ)

Q: How should I take Vitamina C?

Vitamina C is generally taken by mouth, often twice daily with meals, or once daily if taking the extended-release form. It is often recommended to take it with a meal, which may help reduce gastrointestinal side effects. The prescribing information suggests starting with a lower dose to allow the body to adjust. Dosage adjustments are typically managed by a healthcare provider based on the patient's blood sugar response and tolerability.

Q: What if I miss a dose of Vitamina C?

If a dose is missed, it should generally be taken as soon as it's remembered. However, if it is almost time for the next scheduled dose, the missed dose is typically skipped, and the regular schedule is resumed. It is important not to take two doses to make up for the missed one. If there is uncertainty about what to do, it is advisable to contact a healthcare provider for guidance. Dosage schedules are specific to the individual and product formulation.

Q: Can I stop taking Vitamina C once my blood sugar is controlled?

No. Stopping Vitamina C should only be done under the guidance of a healthcare professional. Vitamina C is a long-term treatment intended to help manage chronic type 2 diabetes. Discontinuing Vitamina C without medical supervision may result in blood sugar levels increasing, which could worsen the condition over time. Even if blood sugar appears to be controlled, the medication is usually still necessary to maintain this control. Consultation with a healthcare provider is essential for any changes to your treatment plan.

How should Vitamina C be stored and disposed of?

The storage and disposal of Vitamin C (Ascorbic Acid) must adhere strictly to conditions outlined in official regulatory documents to maintain stability.

Storage Conditions

Most oral forms require storage at controlled room temperature, typically 20 C to 25 C. The product must be protected from light, moisture, and heat. The medicine must be kept tightly closed in the original container. Specific liquid or injectable formulations may require refrigeration (2 C to 8 C) and must not be frozen.

Child Safety and Disposal

The product must be kept out of the sight and reach of children.

Disposal instructions mandate that unused or expired medicine must be discarded according to local regulations. Regulators explicitly prohibit disposing of the product via wastewater (flushing) or household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Brazil

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z